Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Aridis Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 16 | 17 | +1 |
| Shares | 1.93M | 3.88M | +1.96M (+101.6%) |
| Value | $1.79M | $4.58M | +$2.79M (+155.8%) |
New holders (3)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 2,068,000 | $2.44M | 0.07% |
| ICA Group Wealth Management, LLC | 250 | $295 | 0.00% |
| Bank of America Corp | 40 | $48 | 0.00% |
Sold out (2)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Citadel Advisors LLC | 54,386 | $51.0K |
| EP Wealth Advisors, LLC | 50,000 | $47.0K |